JangoBio sees hormone replacement therapy as key to ravages of aging

The degenerative brain disease associated with aging, Alzheimer’s, is a long-standing mystery in the medical world. With 5 million people living with Alzheimer’s disease in the United States alone, new approaches are being taken to discover the unknown causes of the condition.

Craig Atwood, founder of JangoBio, has spent the past 15 years researching the effects of aging-related hormone dysregulation as a cause for Alzheimer’s disease.

JangoBio has been utilizing Atwood’s research to develop a hormone replacement method to curb the effects and common diseases associated with hormone imbalance in both men and women.